Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures

Neurology

Volumn 46, Issue 1, 1996, Pages 49-53

  Willmore, L James ^a   Shu, Vincent ^a   Wallin, Bruce ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; VALPROATE SEMISODIUM;

ABDOMINAL PAIN; ADULT; ANOREXIA; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING;

EID: 0029884831     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.1.49     Document Type: Article

References (26)

1. Crawford P, Chadwick D. A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy. J Neurol Neurosurg Psychiatry 1986;49: 1251-1257.
2. Gram L, Wulff K, Rassmussen KE, et al. Valproate sodium: a controlled clinical trial including monitoring of drug levels. Epilepsia 1977;18:141-148.
3. Richens A, Ahmad S. Controlled trial of sodium valproate in severe epilepsy. Br Med J 1975;4:255-256.
4. Val Elteren PH. On the combination of independent two sample test of Wilcoxon. Bull Inst Int Stat 1960;37:351-361.
5. Lehmann EL. Nonparametrics: statistical methods based on ranks. San Francisco: Holden-Day, 1975.
6. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
7. SAS Institute. SAS user's guide: statistics, version 6.07. 4th ed. Cary, NC: SAS Institute, 1991.
8. COSTART - coding symbols for thesaurus of adverse reaction terms. 3rd ed. Rockville, MD: Food and Drug Administration, Center for Drug Evaluation and Research, 1989.
9. Davis R, Peters DH, McTavish D. Valproic acid: a reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1994;47:332-372.
10. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1985;26:268-278.
11. Berkovic SF, Andermann F, Guberman A, Hipola D, Bladin PF. Valproate prevents the recurrence of absence status. Neurology 1989;39:1294-1297.
12. Bourgeois B, Beaumanoir A, Blajev B, et al. Monotherapy with valproate in primary generalized epilepsies. Epilepsia 1987;28(suppl 2):S8-S11.
13. Clement MJ, Wallace SJ. Juvenile myoclonic epilepsy. Arch Dis Child 1988;63:1049-1053.
14. Coulter DL, Wu H, Allen RJ. Valproic acid therapy in childhood epilepsy. JAMA 1980;244:785-788.
15. Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia 1982;23:693-720.
16. Dean JC, Penry JK. Valproate monotherapy in 30 patients with partial seizures. Epilepsia 1988;29:140-144.
17. Dulac O, Steru D, Rey E, Parret A, Arthuis M. Sodium valproate monotherapy in childhood epilepsy. Brain Dev 1986; 8:47-52.
18. Feuerstein J, Revol M, Roger J, et al. La monotherapie par le valproate de sodium dans les epilepsies generalisees primaires. Deuxieme phase: etude d'efficacite et de tolerance au long cours. Sem Hop 1983;59:1263-1274.
19. Obeid T, Panayiotopoulos CP. Juvenile myoclonic epilepsy: a study in Saudi Arabia. Epilepsia 1988;29:280-282.
20. Penry JK, Dean JC, Riela AR. Juvenile myoclonic epilepsy: long-term response to therapy. Epilepsia 1989;30(suppl 4): S19-S23.
21. Sherard ES Jr, Steiman GS, Couri D. Treatment of childhood epilepsy with valproic acid: results of the first 100 patients in a 6-month trial. Neurology 1980;30:31-35.
22. Spiel G, Feucht M. Valproinsaure-Monotherapie bei Epilepsien im Kindes- und Jugendalter. Pädiatr Pädol 1987;22:267-278.
23. Spitz MC, Deasy DN. Conversion to valproate monotherapy in non-retarded adults with primary generalized tonic-clonic seizures. J Epilepsy 1991;4:33-38.
24. Van Sweden B. VPA syrup in childhood epilepsy: results of an international clinical multicentre trial. Acta Neurol Belg 1988;88:152-162.
25. Heller AJ, Chesterman P, Elwes RDC, et al. Phenobarbitone, phenytoin, carbamazepine or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry 1995;58:44-50.
26. Mattson RH, Cramer JA, Collins JF, Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992;327:765-771.